• In conjunction with the American Uveitis Society

    Uveal Blues in Chicago

    Saturday, Oct. 27, 2018
    McCormick Place, Chicago

    Schedule

    Review the 2018 Uveitis Subspecialty Day schedule.

    Program Directors

    Albert T. Vitale, MD and Hatice N. Sen, MD

    Program Planning Group

    Nisha Acharya, MD; Phoebe Lin, MD, PhD; Hatice N. Sen, MD; Wendy M. Smith, MD; Sunil K. Srivastava, MD; Steven Yeh, MD; Albert T. Vitale, MD

    Mission Statement

    The mission of the 2018 Uveitis Subspecialty Day is to provide attendees with a comprehensive, state-of-the-art update on the treatment and management of uveitis disorders.

    Target Audience

    The intended audience for this program includes general ophthalmologists, comprehensive ophthalmologists, uveitis specialists, other ophthalmologic subspecialists (cornea, retina, etc.), and allied health personnel who are involved in the management of patients with uveitis and ocular inflammatory diseases.

    Education Level

    Intermediate, Advanced

    Goal

    To provide attendees with comprehensive training in and an update on the challenges in the diagnosis and management of uveitis and various ocular inflammatory diseases, and to identify and discuss the current research that may lead to new management approaches and standards of care.

    Program Objectives

    Upon completion of this activity, participants should be able to:

    • Identify the challenges in recognizing the various forms of ocular inflammatory diseases, including anterior, intermediate, posterior and pan uveitis.
    • Construct a differential diagnosis for various forms of uveitis.
    • Classify the principles of diagnosis for ocular inflammatory disorders in order to initiate appropriate disease-directed evaluations.
    • Describe the important and appropriate role of immunomodulatory therapy for patients with selected ocular inflammatory diseases, and also for patients with steroid-dependent inflammation.
    • Describe the potential new treatments for uveitis and ocular inflammatory diseases, including selected therapeutic agents now in development.

    CME Accreditation

    The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Attendees registered as exhibitors, spouses or guests are not eligible for CME credits.

    Find more information about CME.